Published October 19, 2004
In PLoS Medicine, volume 1, issue 1:
Nevirapine and Efavirenz Elicit Different Changes in Lipid Profiles in Antiretroviral-Therapy-Naive Patients Infected with HIV-1
Frank van Leth, Prahpan Phanuphak, Erik Stroes, Brian Gazzard, Pedro Cahn, et al.
DOI: 10.1371/journal.pmed.0010019
The following information was missing from the legend for Figure 1: closed squares, NVP; open squares, EFV; error bars denote standard errors. Oliver Flint at Bristol-Myers Squibb alerted PLoS Medicine to this omission.
Figure 1. Change in Plasma Concentrations of Lipids and Lipoproteins.
Adjusted for sex, region, pVL decrease, and CD4+-cell increase. Closed squares, NVP; open squares, EFV; error bars denote standard errors.
There was also a line with open circles in Figure 1F that should not have been included.
Footnotes
Citation: (2004) Correction: Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1. PLoS Med 1(1): e19.